• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非典型抗精神病药物治疗中QTc间期延长——一项开放性、非随机调查的结果]

[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].

作者信息

Finzel Martin, Fric Mirijam, Laux Gerd

机构信息

Bezirksklinikum Gabersee.

出版信息

Psychiatr Prax. 2004 Nov;31 Suppl 1:S178-80. doi: 10.1055/s-2004-828465.

DOI:10.1055/s-2004-828465
PMID:15570546
Abstract

The introduction of Ziprasidone stimulated discussion about frequency and importance of QTc-interval prolongations with antipsychotic therapy. In an open non-randomized study we collected data about QTc-interval, electrolytes, vital parameters and associated clinical symptoms in patients treated with atypical antipsychotics. 33 patients were scanned and some moderate QTc-interval prolongations but no clinical events were seen. Due to scarcity of such events existing data should be completed by large scale clinical studies and by registration of severe QTc-interval prolongations and torsades de pointes in central drug monitoring systems.

摘要

齐拉西酮的引入引发了关于抗精神病药物治疗导致QTc间期延长的频率和重要性的讨论。在一项开放性非随机研究中,我们收集了接受非典型抗精神病药物治疗患者的QTc间期、电解质、生命体征参数及相关临床症状的数据。对33例患者进行了扫描,发现了一些中度QTc间期延长,但未观察到临床事件。由于此类事件较少,现有数据应由大规模临床研究以及在中央药物监测系统中记录严重QTc间期延长和尖端扭转型室速来补充完善。

相似文献

1
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].[非典型抗精神病药物治疗中QTc间期延长——一项开放性、非随机调查的结果]
Psychiatr Prax. 2004 Nov;31 Suppl 1:S178-80. doi: 10.1055/s-2004-828465.
2
Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.齐拉西酮与QTc间期:药代动力学及药效学考量
Psychopharmacol Bull. 2001 Autumn;35(4):66-79.
3
The safety of atypical antipsychotics: does QTc provide all the answers?非典型抗精神病药物的安全性:QTc 能提供所有答案吗?
Expert Opin Drug Saf. 2011 May;10(3):341-4. doi: 10.1517/14740338.2011.576665. Epub 2011 Apr 20.
4
Schizophrenia, antipsychotic drugs, and cardiovascular disease.精神分裂症、抗精神病药物与心血管疾病
J Clin Psychiatry. 2005;66 Suppl 6:5-10.
5
Torsades de pointes associated with ziprasidone.与齐拉西酮相关的尖端扭转型室性心动过速。
Psychosomatics. 2006 May-Jun;47(3):264-8. doi: 10.1176/appi.psy.47.3.264.
6
[Risk of QTc prolongation due to combination of ziprasidone and quetiapine].[齐拉西酮与喹硫平联用导致QTc延长的风险]
Psychiatr Prax. 2004 Nov;31 Suppl 1:S142-4. doi: 10.1055/s-2004-828458.
7
Ziprasidone in the management of schizophrenia : the QT interval issue in context.齐拉西酮治疗精神分裂症:QT间期问题剖析
CNS Drugs. 2003;17(6):423-30. doi: 10.2165/00023210-200317060-00004.
8
Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.接受齐拉西酮治疗的儿童和青少年的心电图变化:一项前瞻性研究。
J Am Acad Child Adolesc Psychiatry. 2005 Jan;44(1):73-9. doi: 10.1097/01.chi.0000145372.61239.bb.
9
Sulpiride induced torsade de pointes.舒必利诱发尖端扭转型室性心动过速。
Int J Cardiol. 2007 Jun 12;118(3):e100-2. doi: 10.1016/j.ijcard.2007.01.060. Epub 2007 Apr 3.
10
[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].[将精神分裂症患者中与QTc延长相关的风险降至最低。精神分裂症心脏安全小组的共识声明]
Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62.